Gilead eyes remdesivir supplies for 1 million patients by year end
New York, May 1 (SocialNews.XYZ) Amid positive results from two trials of investigational antiviral drug remdesivir on hospitalised COVID-19 patients, its US-based maker Gilead Sciences has said it is ramping up production of the drug…

















